Loading…

Inhibition of aortic aneurysm development in blotchy mice by beta adrenergic blockade independent of altered lysyl oxidase activity

Purpose: This study was designed to define the effects of β-adrenergic blockade on aortic lysyl oxidase (LO), an enzyme responsible for elastin and collagen cross-linking, and aneurysm formation in the blotchy mouse. It was hypothesized that β-blockade would inhibit the development of aneurysms beca...

Full description

Saved in:
Bibliographic Details
Published in:Journal of vascular surgery 1995-05, Vol.21 (5), p.792-800
Main Authors: Moursi, Mohammed M., Beebe, Hugh G., Messina, Louis M., Welling, Theodore H., Stanley, James C.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c473t-1503502cadbbea736836aba0c10f4ecb263ed2b9577459b71bb5f49720df017a3
cites cdi_FETCH-LOGICAL-c473t-1503502cadbbea736836aba0c10f4ecb263ed2b9577459b71bb5f49720df017a3
container_end_page 800
container_issue 5
container_start_page 792
container_title Journal of vascular surgery
container_volume 21
creator Moursi, Mohammed M.
Beebe, Hugh G.
Messina, Louis M.
Welling, Theodore H.
Stanley, James C.
description Purpose: This study was designed to define the effects of β-adrenergic blockade on aortic lysyl oxidase (LO), an enzyme responsible for elastin and collagen cross-linking, and aneurysm formation in the blotchy mouse. It was hypothesized that β-blockade would inhibit the development of aneurysms because of its hemodynamic effect rather than a direct effect on LO activity. Methods: Three groups of mice were studied: group I—normal littermates of blotchy mice; group II—untreated blotchy mice; group III—blotchy mice given either propranolol, atenolol, or nadolol. Data from the three different beta blocker-treated animals, group III, were statistically identical and were combined for analysis. The study was concluded when the mice were 4 months of age. At that time systolic blood pressure, heart rate, and aortic diameters were measured, and the entire aorta from each mouse was subjected to a bioassay for LO activity. Results: Group I normal mice had an aortic arch diameter of 0.10±0.02 cm. Group II blotchy mice developed aortic arch aneurysms with a diameter of 0.21±0.03 cm. In Group III, β blockade reduced the aortic arch diameter in blotchy mice to 0.11±0.03 cm. Mean heart rate in group III β-blocked mice was reduced 25% compared with group I normal mice, and 18% compared with group II untreated blotchy mice. Blood pressures were similar in all three groups. Group II blotchy mice exhibited approximately half of the aortic LO activity (2.43±0.57 cpm/μg protein) noted in group I normal mice (5.82±1.06 cpm/μg protein). Aortic LO activity in group III blotchy mice remained low (2.09±0.85 cpm/μg protein) despite administration of β-blockers. Conclusions: This is the first study to document an actual decrease in the level of aortic LO activity in blotchy mouse. β-Blockade inhibits development of aortic aneurysms in blotchy mice. This is associated with a reduction in heart rate, but not by alterations in LO activity.
doi_str_mv 10.1016/S0741-5214(05)80010-2
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_77308329</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0741521405800102</els_id><sourcerecordid>77308329</sourcerecordid><originalsourceid>FETCH-LOGICAL-c473t-1503502cadbbea736836aba0c10f4ecb263ed2b9577459b71bb5f49720df017a3</originalsourceid><addsrcrecordid>eNqFkE1P3DAQhq2qFWyhPwHJJ9Qe0o7jOE5OVYX6gYTUA3C2_DEBQxIvtnfVnPnjeNkV117sw_u8M5qHkDMGXxmw9ts1yIZVombNZxBfOgAGVf2OrBj0smo76N-T1RtyTD6m9FAYJjp5RI6kbHvJ5Yo8X8733vjsw0zDQHWI2VuqZ9zEJU3U4RbHsJ5wztTP1Iwh2_uFTt4iNQs1mDXVLuKM8a70Sm4ftcPCOlxjeUpvN3bMGNHRcUnLSMM_73RCqm32W5-XU_Jh0GPCT4f_hNz--nlz8ae6-vv78uLHVWUbyXPFBHABtdXOGNSStx1vtdFgGQwNWlO3HF1teiFlI3ojmTFiaHpZgxuASc1PyPl-7jqGpw2mrCafLI5jOTdskpKSQ8frvoBiD9oYUoo4qHX0k46LYqB28tWrfLUzq0CoV_mqLr2zw4KNmdC9tQ62S_59n2O5cusxqmQ9zhadj2izcsH_Z8ML6dWW1g</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>77308329</pqid></control><display><type>article</type><title>Inhibition of aortic aneurysm development in blotchy mice by beta adrenergic blockade independent of altered lysyl oxidase activity</title><source>BACON - Elsevier - GLOBAL_SCIENCEDIRECT-OPENACCESS</source><creator>Moursi, Mohammed M. ; Beebe, Hugh G. ; Messina, Louis M. ; Welling, Theodore H. ; Stanley, James C.</creator><creatorcontrib>Moursi, Mohammed M. ; Beebe, Hugh G. ; Messina, Louis M. ; Welling, Theodore H. ; Stanley, James C.</creatorcontrib><description>Purpose: This study was designed to define the effects of β-adrenergic blockade on aortic lysyl oxidase (LO), an enzyme responsible for elastin and collagen cross-linking, and aneurysm formation in the blotchy mouse. It was hypothesized that β-blockade would inhibit the development of aneurysms because of its hemodynamic effect rather than a direct effect on LO activity. Methods: Three groups of mice were studied: group I—normal littermates of blotchy mice; group II—untreated blotchy mice; group III—blotchy mice given either propranolol, atenolol, or nadolol. Data from the three different beta blocker-treated animals, group III, were statistically identical and were combined for analysis. The study was concluded when the mice were 4 months of age. At that time systolic blood pressure, heart rate, and aortic diameters were measured, and the entire aorta from each mouse was subjected to a bioassay for LO activity. Results: Group I normal mice had an aortic arch diameter of 0.10±0.02 cm. Group II blotchy mice developed aortic arch aneurysms with a diameter of 0.21±0.03 cm. In Group III, β blockade reduced the aortic arch diameter in blotchy mice to 0.11±0.03 cm. Mean heart rate in group III β-blocked mice was reduced 25% compared with group I normal mice, and 18% compared with group II untreated blotchy mice. Blood pressures were similar in all three groups. Group II blotchy mice exhibited approximately half of the aortic LO activity (2.43±0.57 cpm/μg protein) noted in group I normal mice (5.82±1.06 cpm/μg protein). Aortic LO activity in group III blotchy mice remained low (2.09±0.85 cpm/μg protein) despite administration of β-blockers. Conclusions: This is the first study to document an actual decrease in the level of aortic LO activity in blotchy mouse. β-Blockade inhibits development of aortic aneurysms in blotchy mice. This is associated with a reduction in heart rate, but not by alterations in LO activity.</description><identifier>ISSN: 0741-5214</identifier><identifier>EISSN: 1097-6809</identifier><identifier>DOI: 10.1016/S0741-5214(05)80010-2</identifier><identifier>PMID: 7769737</identifier><language>eng</language><publisher>United States: Mosby, Inc</publisher><subject>Animals ; Aorta, Thoracic - drug effects ; Aorta, Thoracic - pathology ; Aortic Aneurysm - enzymology ; Aortic Aneurysm - pathology ; Aortic Aneurysm - physiopathology ; Aortic Aneurysm - prevention &amp; control ; Atenolol - pharmacology ; Atenolol - therapeutic use ; Blood Pressure - drug effects ; Heart Rate - drug effects ; Male ; Mice ; Mice, Mutant Strains ; Nadolol - pharmacology ; Nadolol - therapeutic use ; Propranolol - pharmacology ; Propranolol - therapeutic use ; Protein-Lysine 6-Oxidase - drug effects ; Protein-Lysine 6-Oxidase - metabolism</subject><ispartof>Journal of vascular surgery, 1995-05, Vol.21 (5), p.792-800</ispartof><rights>1995 The Society for Vascular Surgery and the North American Chapter, International Society for Cardiovascular Surgery</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c473t-1503502cadbbea736836aba0c10f4ecb263ed2b9577459b71bb5f49720df017a3</citedby><cites>FETCH-LOGICAL-c473t-1503502cadbbea736836aba0c10f4ecb263ed2b9577459b71bb5f49720df017a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7769737$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Moursi, Mohammed M.</creatorcontrib><creatorcontrib>Beebe, Hugh G.</creatorcontrib><creatorcontrib>Messina, Louis M.</creatorcontrib><creatorcontrib>Welling, Theodore H.</creatorcontrib><creatorcontrib>Stanley, James C.</creatorcontrib><title>Inhibition of aortic aneurysm development in blotchy mice by beta adrenergic blockade independent of altered lysyl oxidase activity</title><title>Journal of vascular surgery</title><addtitle>J Vasc Surg</addtitle><description>Purpose: This study was designed to define the effects of β-adrenergic blockade on aortic lysyl oxidase (LO), an enzyme responsible for elastin and collagen cross-linking, and aneurysm formation in the blotchy mouse. It was hypothesized that β-blockade would inhibit the development of aneurysms because of its hemodynamic effect rather than a direct effect on LO activity. Methods: Three groups of mice were studied: group I—normal littermates of blotchy mice; group II—untreated blotchy mice; group III—blotchy mice given either propranolol, atenolol, or nadolol. Data from the three different beta blocker-treated animals, group III, were statistically identical and were combined for analysis. The study was concluded when the mice were 4 months of age. At that time systolic blood pressure, heart rate, and aortic diameters were measured, and the entire aorta from each mouse was subjected to a bioassay for LO activity. Results: Group I normal mice had an aortic arch diameter of 0.10±0.02 cm. Group II blotchy mice developed aortic arch aneurysms with a diameter of 0.21±0.03 cm. In Group III, β blockade reduced the aortic arch diameter in blotchy mice to 0.11±0.03 cm. Mean heart rate in group III β-blocked mice was reduced 25% compared with group I normal mice, and 18% compared with group II untreated blotchy mice. Blood pressures were similar in all three groups. Group II blotchy mice exhibited approximately half of the aortic LO activity (2.43±0.57 cpm/μg protein) noted in group I normal mice (5.82±1.06 cpm/μg protein). Aortic LO activity in group III blotchy mice remained low (2.09±0.85 cpm/μg protein) despite administration of β-blockers. Conclusions: This is the first study to document an actual decrease in the level of aortic LO activity in blotchy mouse. β-Blockade inhibits development of aortic aneurysms in blotchy mice. This is associated with a reduction in heart rate, but not by alterations in LO activity.</description><subject>Animals</subject><subject>Aorta, Thoracic - drug effects</subject><subject>Aorta, Thoracic - pathology</subject><subject>Aortic Aneurysm - enzymology</subject><subject>Aortic Aneurysm - pathology</subject><subject>Aortic Aneurysm - physiopathology</subject><subject>Aortic Aneurysm - prevention &amp; control</subject><subject>Atenolol - pharmacology</subject><subject>Atenolol - therapeutic use</subject><subject>Blood Pressure - drug effects</subject><subject>Heart Rate - drug effects</subject><subject>Male</subject><subject>Mice</subject><subject>Mice, Mutant Strains</subject><subject>Nadolol - pharmacology</subject><subject>Nadolol - therapeutic use</subject><subject>Propranolol - pharmacology</subject><subject>Propranolol - therapeutic use</subject><subject>Protein-Lysine 6-Oxidase - drug effects</subject><subject>Protein-Lysine 6-Oxidase - metabolism</subject><issn>0741-5214</issn><issn>1097-6809</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1995</creationdate><recordtype>article</recordtype><recordid>eNqFkE1P3DAQhq2qFWyhPwHJJ9Qe0o7jOE5OVYX6gYTUA3C2_DEBQxIvtnfVnPnjeNkV117sw_u8M5qHkDMGXxmw9ts1yIZVombNZxBfOgAGVf2OrBj0smo76N-T1RtyTD6m9FAYJjp5RI6kbHvJ5Yo8X8733vjsw0zDQHWI2VuqZ9zEJU3U4RbHsJ5wztTP1Iwh2_uFTt4iNQs1mDXVLuKM8a70Sm4ftcPCOlxjeUpvN3bMGNHRcUnLSMM_73RCqm32W5-XU_Jh0GPCT4f_hNz--nlz8ae6-vv78uLHVWUbyXPFBHABtdXOGNSStx1vtdFgGQwNWlO3HF1teiFlI3ojmTFiaHpZgxuASc1PyPl-7jqGpw2mrCafLI5jOTdskpKSQ8frvoBiD9oYUoo4qHX0k46LYqB28tWrfLUzq0CoV_mqLr2zw4KNmdC9tQ62S_59n2O5cusxqmQ9zhadj2izcsH_Z8ML6dWW1g</recordid><startdate>19950501</startdate><enddate>19950501</enddate><creator>Moursi, Mohammed M.</creator><creator>Beebe, Hugh G.</creator><creator>Messina, Louis M.</creator><creator>Welling, Theodore H.</creator><creator>Stanley, James C.</creator><general>Mosby, Inc</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19950501</creationdate><title>Inhibition of aortic aneurysm development in blotchy mice by beta adrenergic blockade independent of altered lysyl oxidase activity</title><author>Moursi, Mohammed M. ; Beebe, Hugh G. ; Messina, Louis M. ; Welling, Theodore H. ; Stanley, James C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c473t-1503502cadbbea736836aba0c10f4ecb263ed2b9577459b71bb5f49720df017a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1995</creationdate><topic>Animals</topic><topic>Aorta, Thoracic - drug effects</topic><topic>Aorta, Thoracic - pathology</topic><topic>Aortic Aneurysm - enzymology</topic><topic>Aortic Aneurysm - pathology</topic><topic>Aortic Aneurysm - physiopathology</topic><topic>Aortic Aneurysm - prevention &amp; control</topic><topic>Atenolol - pharmacology</topic><topic>Atenolol - therapeutic use</topic><topic>Blood Pressure - drug effects</topic><topic>Heart Rate - drug effects</topic><topic>Male</topic><topic>Mice</topic><topic>Mice, Mutant Strains</topic><topic>Nadolol - pharmacology</topic><topic>Nadolol - therapeutic use</topic><topic>Propranolol - pharmacology</topic><topic>Propranolol - therapeutic use</topic><topic>Protein-Lysine 6-Oxidase - drug effects</topic><topic>Protein-Lysine 6-Oxidase - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Moursi, Mohammed M.</creatorcontrib><creatorcontrib>Beebe, Hugh G.</creatorcontrib><creatorcontrib>Messina, Louis M.</creatorcontrib><creatorcontrib>Welling, Theodore H.</creatorcontrib><creatorcontrib>Stanley, James C.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of vascular surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Moursi, Mohammed M.</au><au>Beebe, Hugh G.</au><au>Messina, Louis M.</au><au>Welling, Theodore H.</au><au>Stanley, James C.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Inhibition of aortic aneurysm development in blotchy mice by beta adrenergic blockade independent of altered lysyl oxidase activity</atitle><jtitle>Journal of vascular surgery</jtitle><addtitle>J Vasc Surg</addtitle><date>1995-05-01</date><risdate>1995</risdate><volume>21</volume><issue>5</issue><spage>792</spage><epage>800</epage><pages>792-800</pages><issn>0741-5214</issn><eissn>1097-6809</eissn><abstract>Purpose: This study was designed to define the effects of β-adrenergic blockade on aortic lysyl oxidase (LO), an enzyme responsible for elastin and collagen cross-linking, and aneurysm formation in the blotchy mouse. It was hypothesized that β-blockade would inhibit the development of aneurysms because of its hemodynamic effect rather than a direct effect on LO activity. Methods: Three groups of mice were studied: group I—normal littermates of blotchy mice; group II—untreated blotchy mice; group III—blotchy mice given either propranolol, atenolol, or nadolol. Data from the three different beta blocker-treated animals, group III, were statistically identical and were combined for analysis. The study was concluded when the mice were 4 months of age. At that time systolic blood pressure, heart rate, and aortic diameters were measured, and the entire aorta from each mouse was subjected to a bioassay for LO activity. Results: Group I normal mice had an aortic arch diameter of 0.10±0.02 cm. Group II blotchy mice developed aortic arch aneurysms with a diameter of 0.21±0.03 cm. In Group III, β blockade reduced the aortic arch diameter in blotchy mice to 0.11±0.03 cm. Mean heart rate in group III β-blocked mice was reduced 25% compared with group I normal mice, and 18% compared with group II untreated blotchy mice. Blood pressures were similar in all three groups. Group II blotchy mice exhibited approximately half of the aortic LO activity (2.43±0.57 cpm/μg protein) noted in group I normal mice (5.82±1.06 cpm/μg protein). Aortic LO activity in group III blotchy mice remained low (2.09±0.85 cpm/μg protein) despite administration of β-blockers. Conclusions: This is the first study to document an actual decrease in the level of aortic LO activity in blotchy mouse. β-Blockade inhibits development of aortic aneurysms in blotchy mice. This is associated with a reduction in heart rate, but not by alterations in LO activity.</abstract><cop>United States</cop><pub>Mosby, Inc</pub><pmid>7769737</pmid><doi>10.1016/S0741-5214(05)80010-2</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0741-5214
ispartof Journal of vascular surgery, 1995-05, Vol.21 (5), p.792-800
issn 0741-5214
1097-6809
language eng
recordid cdi_proquest_miscellaneous_77308329
source BACON - Elsevier - GLOBAL_SCIENCEDIRECT-OPENACCESS
subjects Animals
Aorta, Thoracic - drug effects
Aorta, Thoracic - pathology
Aortic Aneurysm - enzymology
Aortic Aneurysm - pathology
Aortic Aneurysm - physiopathology
Aortic Aneurysm - prevention & control
Atenolol - pharmacology
Atenolol - therapeutic use
Blood Pressure - drug effects
Heart Rate - drug effects
Male
Mice
Mice, Mutant Strains
Nadolol - pharmacology
Nadolol - therapeutic use
Propranolol - pharmacology
Propranolol - therapeutic use
Protein-Lysine 6-Oxidase - drug effects
Protein-Lysine 6-Oxidase - metabolism
title Inhibition of aortic aneurysm development in blotchy mice by beta adrenergic blockade independent of altered lysyl oxidase activity
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T15%3A03%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Inhibition%20of%20aortic%20aneurysm%20development%20in%20blotchy%20mice%20by%20beta%20adrenergic%20blockade%20independent%20of%20altered%20lysyl%20oxidase%20activity&rft.jtitle=Journal%20of%20vascular%20surgery&rft.au=Moursi,%20Mohammed%20M.&rft.date=1995-05-01&rft.volume=21&rft.issue=5&rft.spage=792&rft.epage=800&rft.pages=792-800&rft.issn=0741-5214&rft.eissn=1097-6809&rft_id=info:doi/10.1016/S0741-5214(05)80010-2&rft_dat=%3Cproquest_cross%3E77308329%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c473t-1503502cadbbea736836aba0c10f4ecb263ed2b9577459b71bb5f49720df017a3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=77308329&rft_id=info:pmid/7769737&rfr_iscdi=true